Zepto: more than a capsulotomy device

Zepto: more than a capsulotomy device

The Zepto capsulotomy system (Mynosys Cellular Devices, Fremont, California) entered the U.S. market in June 2017, and since then, surgeons have found the automated capsulotomy device provides numerous clinical benefits. By shortening surgery time, providing consistent, circular capsulotomies, preserving visual axis information during surgery, and reducing risks of some complications, the Zepto device makes complex cases routine and can even extend a seasoned surgeon’s career, according to physicians who use it regularly.

Source: https://www.eyeworld.org/

Leave a Reply

Close Menu